Article

An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodies

2020-12-18

Abstract excerpt

SARS-CoV-2 infection causes severe symptoms in a subset of patients, suggesting the presence of certain unknown risk factors. Although antibodies against the receptor-binding domain (RBD) of the SARS-CoV-2 spike have been shown prevent SARS-CoV-2 infection, the effects of antibodies against other spike protein domains are largely unknown. Here, we screened a series of anti-spike monoclonal antibodies from COVID-19...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 43a0cf0c-53ac-54c6-8433-c8216a60fe3d
DOI: 10.1101/2020.12.18.423358

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodiesDOI 10.1101/2020.12.18.423358Read

Neutralizing antibodies targeting SARS-CoV-2 spike proteinSemantic proximity Read

Characterization of neutralizing antibodies from a SARS-CoV-2 infected individualSemantic proximity Read

Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralizationSemantic proximity Read

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodiesSemantic proximity Read

Sequence variation of SARS-CoV-2 spike protein may facilitate stronger interaction with ACE2 promoting high infectivitySemantic proximity Read

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.Semantic proximity Read

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced ImmunitySemantic proximity Read

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants.Semantic proximity Read

Spike Proteins of SARS –CoV-2: a detailed perspective on structure, receptor binding, antigenicity, vaccine development and neutralizationSemantic proximity Read

Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasionSemantic proximity Read

SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infectionSemantic proximity Read

Potent anti-SARS-CoV-2 Antibody Responses are Associated with Better Prognosis in Hospital Inpatient COVID-19 DiseaseSemantic proximity Read